Advancell is active in nanomedicine. The company has two divisions: Pharma, which focuses its activity on the development of innovative drugs through the search for new applications for already-known molecules, and Services and Reagents, which uses cell-based in vitro methods to predict the efficacy, safety and mechanism of action of developing molecules.
The company's technology is based on the large scale production of nanometric particles known as VLPs (virus like particles). The most advanced application of this technology is the production of viral vector derived vaccines for human and animal health.
Nanoimmunotech is a Spanish company in the Nanobiotechnology sector, founded in August 2009, recognized as EIBT (Technologically Innovative Company) and Spin-off of form the Universities of Vigo and Zaragoza. It is the first European company dedicated to the biological and physico-chemical characterization and functionalization of nanoparticles (conjugation with different molecules such as nucleid acids, enzimes, antibodies, carbohydrates, peptides) and production of specific monoclonal antibodies (on demand).